-
Updated guidance on nitrosamine impurities in human medicines
Updated guidance on nitrosamine impurities in human medicines
-
Updated guidance on nitrosamine impurities in human medicines
Updated guidance on nitrosamine impurities in human medicines
EMA has published updated guidance for companies on how to limit nitrosamine impurities in human medicines.
-
Annual report 2019
Annual report 2019
-
Annual report 2019
Annual report 2019
The report showcases the Agency’s efforts to protect and promote human and animal health in Europe and highlights the most significant achievements in 2019. For the first time, EMA’s annual report is available in a digital version.
-
CHMP highlights: July 2020
CHMP highlights: July 2020
-
CHMP highlights: July 2020
CHMP highlights: July 2020
EMA’s human medicines committee (CHMP) recommended eleven medicines for approval at its July 2020 meeting, including a medicine for use in countries outside the European Union.
-
COVID-19: latest updates
COVID-19: latest updates
-
COVID-19: latest updates
COVID-19: latest updates
Keep up to date with the latest information from EMA on the COVID-19 pandemic.
